Skip to main content

and
  1. No Access

    Article

    Cancer cachexia’s metabolic signature in a murine model confirms a distinct entity

    Despite recent consensus definitions, lack of specific biomarkers remains a hurdle towards a more accurate and efficient diagnosis of cancer cachexia, distinguishing cachexia as a separate entity from other wa...

    Hirak Der-Torossian, Scott A. Asher, Jason H. Winnike, Ashley Wysong in Metabolomics (2013)

  2. Article

    Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia

    Cancer cachexia is a severe wasting syndrome characterized by the progressive loss of lean body mass and systemic inflammation. Inhibiting the signaling of the transcription factor nuclear factor kappa B (NF-κ...

    Hirak Der-Torossian, Ashley Wysong in Journal of Cachexia, Sarcopenia and Muscle (2013)

  3. No Access

    Article

    Metabolomic analysis of cancer cachexia reveals distinct lipid and glucose alterations

    Cancer cachexia remains a challenging clinical problem with complex pathophysiology and unreliable diagnostic tools. A blood test to detect this metabolic derangement would aid in early treatment of these pati...

    Thomas M. O’Connell, Farhad Ardeshirpour, Scott A. Asher, Jason H. Winnike in Metabolomics (2008)